Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...
FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to ...
manilatimes7d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...
Indiatimes18d
Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check here
On January 1, pharmaceutical companies will also lower some of their prices. The list price of Merck & Co.'s heavily discounted diabetes medications Januvia and Janumet will be lowered "to align the ...
thehealthy18d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
Many diabetes patients have experienced lowered drug costs in recent years, thanks to policies that have capped the price of diabetes prescriptions. For patients who have been paying for Ozempic or ...
lewisherald18d
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
December 23, 2024, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor ...
Forbes19d
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
But a new report from GlobalData indicates Zepbound is poised to overtake other GLP-1 drugs. “Zepbound’s superior efficacy and strategic market expansion suggest that the drug will dominate ...
Managed Healthcare Executive19d
FDA Issues Complete Response for Zynquista in Type 1 Diabetes
In November 2024, a regulatory advisory board said the benefits of Zynquista does not outweigh the risks in adults with type 1 diabetes and chronic kidney disease. The FDA has issued a complete ...
Tempo20d
Jeju Air Boeing 737-800: Specifications and History of Accidents
Lee Geun-young/via REUTERS According to the Altitude Flight Simulation Center, the Boeing 737-800 is part of the Next Generation (NG) 737 series, which also includes the 737-600, 737-700, and 737-900 ...
NDTV23d
People In USA Left Amazed When They're Calling 1-800-242-8478. Here's Why
(Representational) Something unusual happened when a journalist in New York called a toll-free 1-800 number last week. The reason for the call wasn't to reach a particular product helpline ...